The Role of Efflux Pumps in the Transition from Low-Level to Clinical Antibiotic Resistance
Antibiotic resistance is on the rise and has become one of the biggest public health challenges of our time. Bacteria are able to adapt to the selective pressure exerted by antibiotics in numerous ways, including the (over)expression of efflux pumps, which represents an ancient bacterial defense mec...
Main Authors: | Anna Elisabeth Ebbensgaard, Anders Løbner-Olesen, Jakob Frimodt-Møller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/9/12/855 |
Similar Items
-
What Approaches to Thwart Bacterial Efflux Pumps-Mediated Resistance?
by: Armel Jackson Seukep, et al.
Published: (2022-09-01) -
Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives
by: Giada Cernicchi, et al.
Published: (2021-11-01) -
Antibiotic resistance in Salmonella: Targeting multidrug resistance by understanding efflux pumps, regulators and the inhibitors
by: Rawaf Alenazy
Published: (2022-10-01) -
Efflux pump blockers in Gram-negative bacteria:The new generation of hydantoin based-modulators to improve antibiotic activity
by: Ewa eOtrębska-Machaj, et al.
Published: (2016-05-01) -
Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?
by: Renata Claro Ribeiro do Amaral, et al.
Published: (2020-11-01)